Detumomab is a mouse monoclonal antibody targeting human B-cell lymphoma. "International Nonproprietary Names (INN) for Pharmaceutical Substances" (PDF)...
2 KB (74 words) - 00:54, 14 May 2023
biotin mab chimeric histone complex recurrent glioblastoma multiforme Detumomab mab mouse B-lymphoma cell lymphoma Dezamizumab mab humanized serum amyloid...
136 KB (4,020 words) - 06:13, 27 September 2024
(INN) detorubicin (INN) detralfate (INN) Detrol detrothyronine (INN) detumomab (INN) deuruxolitinib (INN) devapamil (INN) devazepide (INN) Dexacen-4...
13 KB (567 words) - 20:24, 26 July 2024
Anatumomab mafenatox Arcitumomab Bectumomab Blinatumomab Capromab pendetide Detumomab Edrecolomab Ibritumomab tiuxetan Igovomab Lilotomab Minretumomab Mitumomab...
5 KB (368 words) - 15:29, 21 August 2024
Anatumomab mafenatox Arcitumomab Bectumomab Blinatumomab Capromab pendetide Detumomab Edrecolomab Ibritumomab tiuxetan Igovomab Lilotomab Minretumomab Mitumomab...
3 KB (129 words) - 01:04, 19 July 2023
Anatumomab mafenatox Arcitumomab Bectumomab Blinatumomab Capromab pendetide Detumomab Edrecolomab Ibritumomab tiuxetan Igovomab Lilotomab Minretumomab Mitumomab...
4 KB (241 words) - 13:42, 14 July 2024